EPA World Congress 2022

March 22-24, 2022, Amsterdam
Events
Category:
Published on:
February 2, 2022

We are thrilled to sponsor and attend World EPA Congress 2022, Europe’s Leading Pricing, Market Access and Evidence Congress for the Biopharma Industry.

The event will feature 250 speakers, multiple streams, and over 1000 attendees from pharma, biotech, and Payers/HTA’s. The 2022 edition will now take place over three days with expanded content on RWE, HTA, Medical Devices, Affordability, Digital Health, Analytics and Emerging Markets. The event’s core topic areas will include Market Access and Pricing, Rare Diseases, HTA/Payer, and Evidence and will cover the latest trends in reimbursement, payment models, affordability, HEOR, and many other developments within the industry.

As part of the event, our very own Andrea Mantovani, Vice President, Global Market Access will also host a roundtable “Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective”.

Our attendees:

 

Related news

Blog March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
News January 18, 2024
Alira Health and Biocat Announce Startup Support Program for 2024
Alira Health and Biocat, a strategic stakeholder building the Catalan life sciences and ecosystem, partnered to foster Market Access for startups.
Market Access Startups
Events January 17, 2024
Presentation: Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain
On January 23rd we will present the results of the first phase of the “Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain.”
Market Access Patient Engagement Spain
Case Studies January 8, 2024
Pharma Company Extends to New Markets through Strategic Licensing Agreements
A Swedish pharma company saw a market opportunity to expand access to its proprietary product outside of the Nordics and sought support developing strategic licensing deals.
Market Access Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.